(Q40347805)

19 September 2017

title

Neuroleptic antagonism of dyskinetic phenomena (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2999(75)90174-0

7 June 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0014-2999(75)90174-0

7 June 2022

author name string

B. Costall

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A241654

7 June 2022

R. J. Naylor

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A241654

7 June 2022

language of work or name

English

0 references

publication date

1 September 1975

1 reference

full work available at URL

19 September 2017

https://api.elsevier.com/content/article/PII:0014299975901740?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(75)90174-0

https://api.elsevier.com/content/article/PII:0014299975901740?httpAccept=text/plain

7 June 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2999(75)90174-0

European Journal of Pharmacology

7 June 2022

published in

1 reference

19 September 2017

volume

33

1 reference

19 September 2017

issue

2

1 reference

19 September 2017

page(s)

301-312

1 reference

Neuropathological investigation of 28 brains from patients with dyskinesia

19 September 2017

cites work

6

1 reference

https://api.crossref.org/works/10.1016/0014-2999(75)90174-0

Specific asymmetric behavior induced by the direct chemical stimulation of neostriatal dopaminergic mechanisms.

7 June 2022

7

1 reference

https://api.crossref.org/works/10.1016/0014-2999(75)90174-0

On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activity

7 June 2022

8

1 reference

https://api.crossref.org/works/10.1016/0014-2999(75)90174-0

Design of agents for stimulation of neostriatal dopaminergic mechanisms.

7 June 2022

9

1 reference

https://api.crossref.org/works/10.1016/0014-2999(75)90174-0

Dyskinetic phenomena caused by the intrastriatal injection of phenylethylamine, phenylpiperazine, tetrahydroisoquinoline and tetrahydronaphthalene derivatives in the guinea pig

7 June 2022

10

1 reference

https://api.crossref.org/works/10.1016/0014-2999(75)90174-0

Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature

7 June 2022

11

1 reference

https://api.crossref.org/works/10.1016/0014-2999(75)90174-0

Management of tardive dyskinesia with thiopropazate.

7 June 2022

12

1 reference

https://api.crossref.org/works/10.1016/0014-2999(75)90174-0

Methylphenidate in Tardive Dyskinesia

7 June 2022

14

1 reference

https://api.crossref.org/works/10.1016/0014-2999(75)90174-0

Combined nitoman-pimozide treatment of Huntington's chorea and other hyperkinetic syndromes

7 June 2022

16

1 reference

https://api.crossref.org/works/10.1016/0014-2999(75)90174-0

Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia

7 June 2022

17

1 reference

https://api.crossref.org/works/10.1016/0014-2999(75)90174-0

Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.

7 June 2022

20

1 reference

https://api.crossref.org/works/10.1016/0014-2999(75)90174-0

Mechanisms of tremor induction by harmine

7 June 2022

22

1 reference

https://api.crossref.org/works/10.1016/0014-2999(75)90174-0

Theoretical implications of the use of L-dopa in parkinsonism. A review

7 June 2022

0 references

Adverse clinical side effects of levodopa therapy

2

1 reference

https://api.crossref.org/works/10.1016/0014-2999(75)90174-0

Dopaminergic mechanisms in patients with extrapyramidal disease

27 January 2023

5

1 reference

https://api.crossref.org/works/10.1016/0014-2999(75)90174-0

An experimental model of tardive dyskinesia

27 January 2023

25

1 reference

https://api.crossref.org/works/10.1016/0014-2999(75)90174-0

Pathophysiology of drug-induced dyskinesias

27 January 2023

26

1 reference

https://api.crossref.org/works/10.1016/0014-2999(75)90174-0

The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias)

27 January 2023

28

1 reference

https://api.crossref.org/works/10.1016/0014-2999(75)90174-0

Actions of dopaminergic agonists in parkinsonism

27 January 2023

30

1 reference

https://api.crossref.org/works/10.1016/0014-2999(75)90174-0

27 January 2023

Identifiers

1 reference

19 September 2017

1 reference